Your session is about to expire
← Back to Search
District health information package for Infectious Diseases (DESH Trial)
N/A
Waitlist Available
Led By Onil Bhattacharyya, MD, PhD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
All districts in India in existence in 2001
Timeline
Screening 3 weeks
Treatment Varies
Follow Up five years
Awards & highlights
Summary
The purpose of this study is to assess the impact of disseminating information on comparative performance, along with actionable messages on how to improve health outcomes, to district-level decision-makers in India using a randomized, controlled design. This information should improve prioritization of health services by district health officers, budget allocation for health, and implementation of priority health services at the district level.
Eligible Conditions
- Infectious Diseases
- Cardiovascular Disease
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ five years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~five years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percentage children 12-23 months vaccinated against measles
Percentage children <3 yrs with diarrhea in past 2 weeks given oral rehydration solution
Percentage facility-based births for the last child since 2007
Secondary study objectives
Percentage community health centres with at least 1 surgeon or ob/gyn
Breast
Percentage public health centres with reagents, light microscope and lab technician for malaria blood smear
+2 moreOther study objectives
Differences in any of primary and between Empowered Action Group and Assam (EAGA) states and non-EAGA states
Differences in any of primary and between measles-focus states and non-measles-focus states
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: District health information packageExperimental Treatment1 Intervention
Group II: No InterventionActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Lombard Insurance Global Poverty Action LabUNKNOWN
Canadian International Development AgencyOTHER_GOV
12 Previous Clinical Trials
899,631 Total Patients Enrolled
Unity Health TorontoLead Sponsor
554 Previous Clinical Trials
453,697 Total Patients Enrolled
1 Trials studying Infectious Diseases
550 Patients Enrolled for Infectious Diseases
Share this study with friends
Copy Link
Messenger